The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 141-150

  Patel, Sonal ^a   Parkin, Susan M ^a   Bibby, Mike C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

5,6 MeXAA; Human and immune cells; Murine; TNF

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; MESSENGER RNA; MITOFLAXONE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CELL STRAIN HL 60; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CYTOKINES; FLAVONOIDS; HUMANS; MICE; MONOCYTES; POLYMERASE CHAIN REACTION; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; XANTHENES; XANTHONES;

EID: 0031052953     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rewcastle GW, Atwell GJ, Baguley BC Calveley SB, Denny WA: Synthesis and structure activity relationships for substituted xanthenone-4-acetic acids against the Colon 38 tumour in vivo. J Med Chem 32: 793-799, 1989.
2. Kerr DJ, Kaye SB, Cassidy J, Dutta S, Setanoians A, Forrest G, Cunningham G, Soukop M, Vezin WR: A clinical pharmacokinetic study of LM985 and LM975. Br J Cancer 52:467, 1905.
3. Cummings J, Double JA, Bibby MC, Farmer P, Evans S, Kerr DJ, Kaye SB, Smyth JF: Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice. Cancer Res 497: 3587-3593, 1989.
4. Plowman J, Narayanan VL, Dykes D, Szarrasi E, Briet P, Yoder OC, Paull KD: Flavone acetic acid: a novel agent with preclinical anti- tumour activity against colon adenocarcinoma 38 in mice. Cancer Treat Rep 70: 631-635, 1986.
5. Bibby MC. Double JA: Flavone acetic acid - from laboratory to clinic and back. Anti Cancer Drugs 4: 3-17, 1993.
6. Ching LM. Baguley BC: Induction of natural killer cell activity by the anti-tumour compound flavone acetic acid (NSC 347512). Eur J Cancer Clin. Oncol 23: 1047-1050, 1987.
7. Thomsen LL, Ching LM, Joseph WR, Baguley BC, Gavin JB: Nitricoxide production in endotoxin resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues. Biochem. Pharmacol 43: 2401-2406, 1992c.
8. Hornung RL, Young HA, Urba WJ, Wiltrout RH: Immunomodulation of natural killer cell activity by flavone acetic acid occurrence via induction of Interferon α/β. J Natl Cancer Inst 80: 1226-1231, 1988b.
9. Bibby MC, Double JA, Loadman PM et al: Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. J Natl Cancer Inst 81: 216-220, 1989.
10. Mahadevan V, Malik STA, Meager A, Fiers W, Lewis GP, Hart IR: Role of tumour necrosis factor in flavone acetic acid-induced tumour vasculature shutdown. Cancer Res 50: 5537-5542, 1990.
11. Philpott M, Baguley BC, Ching L-M: Induction of tumour necrosis factor-α by single and repeated closes of the antitumour agent 5,6- dimethylxanthenone-4-acetic acid. Cancer Chemother. Pharmacol 36: 143-148, 1995.
12. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21: 77-89, 1968.
13. Vodinelich L, Lennox ES: In vitro tumour cytotoxicity assays for macrophage activation. In: lymphokines and interferons: a practical approach. (Clemens, M.J, Morris, A.G. and Gearing, A.J.H, eds). IRL Press 1987, pp 259-266.
14. Ralph P, Prichard J, Conn M: Reticulum cell sarcoma: an effector cell in antibodydependant cell-mediated immunity. J Immunol, 114: 898- 905, 1975.
15. Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347-349, 1977.
16. Fischer DG, Pike MC, Koren HS, Snyderman R: Chemotactically responsive and nonresponsive forms of a continues human monocyte cell line. J Immunol 1: 463-465, 1980.
17. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI-164 clone, for measuring cytotoxic factor/tumour necrosis factor from human monocytes. J Immunological Methods 95: 99-105, 1986.
18. Ng S, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L: Evolution of the functional human B-actin gene and its multipseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Molecular and Cellular Biology 5: 2720-2732, 1985.
19. Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV: Cloning and expression in escherichia coli of the cDNA for murine tumour necrosis factor. Proc Natl Acad Sci USA 82: 6060-6064, 1985.
20. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumour necrosis factor; precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729, 1984.
21. Phillips RM, Sarang M, Gibson NW: Semi-quantitative measurement of gene expression by RT-PCR: A cautionary tale. Int. J Oncol 3: 1007-1102, 1993.
22. Murphy E, Hieny S, Sher A, O'Garra A: Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in schistosoma mansoni infected mice. J Immimological Methods 162: 211-223, 1993.
23. Futami H, Eader LA, Komschlies KL, Bull R, Gruys ME, Ortaldo JR, Young HA, Wiltrout RH: Flavone acetic-acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes. Cancer Res 51: 6596-6602, 1991.
24. Eader LA, Gusella L, Dorman L, Young HA: Induction of multiple cytokine gene expression and IRF-1 mRNA by flavone acetic acid in a murine macrophage cell line. Cellular Immunol 157: 211-222, 1994.
25. Ching L-M, Joseph WR, Crosier KE, Baguley BC: Induction of tumour necrosis factor α messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Cancer Res 54: 870-872, 1994.
26. Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobson B, Odum N, Svejgaard A: Association between HLA-DR2 and production of tumour necrosis factor-α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immonol 28:599-606, 1988.
27. Murray JC, Gauss M, Denekamp J, Stern D: Selective induction of endothelial-cell tissue factor in the presence of a tumour-derived mediator-a potential mechanism of flavone acetic-acid action in tumour vasculature. Int J Cancer 49: 254-259, 1991.
28. Stricter RM, Remick DG, Lynch JP, III. Genord M, Railford C, Spengler R, Kunkel SL: Differential regulation of tumour necrosis factor α in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am J Respir Cell Mol Biol 1: 57-63, 1989.
29. Beutler B, Krochin N, Milsark IW, Lutdke C, Cerami A: Control of cachetin (tumour necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977-980, 1986.
30. Ching L-M, Joseph WR, Zhuang G, Baguley BC: Interaction between endotoxin and the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemor-rhagic necrosis of colon 38 tumours. Cancer Chemother Pharmacol 35: 153- 160, 1994.
31. Mace KF, Hornung RL, Wiltrout RH, Young HA: Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer. Cancer Res 50: 1742-1747, 1991.